Product NDC: | 63323-426 |
Proprietary Name: | Rocuronium |
Non Proprietary Name: | ROCURONIUM BROMIDE |
Active Ingredient(s): | 10 mg/mL & nbsp; ROCURONIUM BROMIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-426 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078651 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091213 |
Package NDC: | 63323-426-05 |
Package Description: | 10 VIAL in 1 TRAY (63323-426-05) > 5 mL in 1 VIAL |
NDC Code | 63323-426-05 |
Proprietary Name | Rocuronium |
Package Description | 10 VIAL in 1 TRAY (63323-426-05) > 5 mL in 1 VIAL |
Product NDC | 63323-426 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ROCURONIUM BROMIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20091213 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | ROCURONIUM BROMIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |